Tender detail
Open-house discount agreements for the biologic Anakinra, 2026–36
Summary
The participating health insurers are seeking discount agreements with pharmaceutical companies for the active ingredient Anakinra. The agreements may run for up to 24 months from 1 January 2027 and end no later than 31 December 2028, regardless of the signing date.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.